144 related articles for article (PubMed ID: 3280634)
1. Risk factors for the development of malignant melanoma--I: Review of case-control studies.
Evans RD; Kopf AW; Lew RA; Rigel DS; Bart RS; Friedman RJ; Rivers JK
J Dermatol Surg Oncol; 1988 Apr; 14(4):393-408. PubMed ID: 3280634
[TBL] [Abstract][Full Text] [Related]
2. Multicenter case-control study of risk factors for cutaneous melanoma in Valencia, Spain.
Ballester I; Oliver V; Bañuls J; Moragón M; Valcuende F; Botella-Estrada R; Nagore E
Actas Dermosifiliogr; 2012 Nov; 103(9):790-7. PubMed ID: 22626452
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors.
Holly EA; Aston DA; Cress RD; Ahn DK; Kristiansen JJ
Am J Epidemiol; 1995 May; 141(10):934-42. PubMed ID: 7741123
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for cutaneous melanoma: case-control study in Córdoba, Argentina].
Ruiz Lascano A; Kuznitzky R; Cuestas E; Mainardi C; Albertini R; Borello A; Kurpis M; Campana R; Palazzo E
Medicina (B Aires); 2004; 64(6):504-8. PubMed ID: 15637827
[TBL] [Abstract][Full Text] [Related]
5. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil.
Bakos L; Wagner M; Bakos RM; Leite CS; Sperhacke CL; Dzekaniak KS; Gleisner AL
Int J Dermatol; 2002 Sep; 41(9):557-62. PubMed ID: 12358823
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure.
White E; Kirkpatrick CS; Lee JA
Am J Epidemiol; 1994 May; 139(9):857-68. PubMed ID: 8166136
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for cutaneous melanoma: a case-control study in Argentina.
Loria D; Matos E
Int J Dermatol; 2001 Feb; 40(2):108-14. PubMed ID: 11328391
[TBL] [Abstract][Full Text] [Related]
8. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
9. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study.
Lock-Andersen J; Drzewiecki KT; Wulf HC
Acta Derm Venereol; 1999 Jan; 79(1):74-80. PubMed ID: 10086866
[TBL] [Abstract][Full Text] [Related]
10. Incidence, risk factors and prevention of melanoma.
MacKie RM
Eur J Cancer; 1998 Jul; 34 Suppl 3():S3-6. PubMed ID: 9849401
[TBL] [Abstract][Full Text] [Related]
11. Use of host factors to identify people at high risk for cutaneous malignant melanoma .
Marrett LD; King WD; Walter SD; From L
CMAJ; 1992 Aug; 147(4):445-53. PubMed ID: 1498755
[TBL] [Abstract][Full Text] [Related]
12. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia.
Youl P; Aitken J; Hayward N; Hogg D; Liu L; Lassam N; Martin N; Green A
Int J Cancer; 2002 Mar; 98(1):92-8. PubMed ID: 11857391
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.
Cress RD; Holly EA; Ahn DK; LeBoit PE; Sagebiel RW
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):831-6. PubMed ID: 8634653
[TBL] [Abstract][Full Text] [Related]
14. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi.
Veierød MB; Adami HO; Lund E; Armstrong BK; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):111-20. PubMed ID: 20056629
[TBL] [Abstract][Full Text] [Related]
15. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
16. The simultaneous assessment of constitutional, behavioral, and environmental factors in the development of large nevi.
Cockburn M; Hamilton A; Mack T
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):200-6. PubMed ID: 17267390
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of malignant melanoma in Israeli kibbutzim.
Tabenkin H; Tamir A; Sperber AD; Shapira M; Shvartzman P
Isr Med Assoc J; 1999 Nov; 1(3):154-7. PubMed ID: 10731323
[TBL] [Abstract][Full Text] [Related]
18. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
19. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.
Grulich AE; Bataille V; Swerdlow AJ; Newton-Bishop JA; Cuzick J; Hersey P; McCarthy WH
Int J Cancer; 1996 Aug; 67(4):485-91. PubMed ID: 8759605
[TBL] [Abstract][Full Text] [Related]
20. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
